Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Cash & Equivalents: 2013-2025

Historic Cash & Equivalents for Scynexis (SCYX) over the last 13 years, with Sep 2025 value amounting to $37.9 million.

  • Scynexis' Cash & Equivalents fell 55.36% to $37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year decrease of 55.36%. This contributed to the annual value of $16.1 million for FY2024, which is 52.86% down from last year.
  • Scynexis' Cash & Equivalents amounted to $37.9 million in Q3 2025, which was down 18.49% from $46.5 million recorded in Q2 2025.
  • Over the past 5 years, Scynexis' Cash & Equivalents peaked at $118.7 million during Q2 2022, and registered a low of $16.1 million during Q4 2024.
  • Its 3-year average for Cash & Equivalents is $63.9 million, with a median of $54.8 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 354.31% in 2021, then plummeted by 56.15% in 2022.
  • Quarterly analysis of 5 years shows Scynexis' Cash & Equivalents stood at $104.5 million in 2021, then tumbled by 56.15% to $45.8 million in 2022, then decreased by 25.68% to $34.0 million in 2023, then plummeted by 52.86% to $16.1 million in 2024, then tumbled by 55.36% to $37.9 million in 2025.
  • Its Cash & Equivalents was $37.9 million in Q3 2025, compared to $46.5 million in Q2 2025 and $53.8 million in Q1 2025.